Cagrilintide

A long-acting amylin receptor agonist researched for satiety and weight management in combination with semaglutide (CagriSema).

SELECT SIZE

PRICE PER VIALCA$80.00CAD

10+ VIALSCA$680.0015% BULK DISCOUNT

5mg per vial · mg/vial

Cagrilintide is an investigational long-acting amylin analog designed for weekly subcutaneous administration. It acts on amylin receptors in the brain to promote satiety and slow gastric emptying. The CagriSema combination (cagrilintide + semaglutide) has shown remarkable weight loss outcomes of up to 22.7% in REDEFINE clinical trials, demonstrating the synergistic potential of dual amylin/GLP-1 receptor activation.

Key Research Applications

Amylin receptor agonist

Satiety promotion research

CagriSema combination studies

Weekly dosing protocol

Gastric emptying modulation

Research Dosage Calculator

RESEARCH PROTOCOL

DURATION4 weeks

1 wk24 wks

CALCULATED REQUIREMENTS

DOSE PER INJECTION0.5 mg

TOTAL INJECTIONS4

TOTAL mg NEEDED2 mg

VIALS REQUIRED1 vial

RECONSTITUTION GUIDE (per 5mg vial + 1mL BAC water)Draw 0.100 mL per injection

ESTIMATED COST~$NaN USD

For research use only. Dosage calculations are estimates based on published research protocols. Consult primary literature for your specific research application.